Growth Metrics

Biolife Solutions (BLFS) Shares Outstanding (Diluted Average) (2017 - 2025)

Biolife Solutions (BLFS) has disclosed Shares Outstanding (Diluted Average) for 9 consecutive years, with $48.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 5.6% to $48.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $48.6 million, a 5.6% increase, with the full-year FY2025 number at $48.6 million, up 5.6% from a year prior.
  • Shares Outstanding (Diluted Average) was $48.6 million for Q4 2025 at Biolife Solutions, roughly flat from $48.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $48.7 million in Q3 2025 to a low of $38.5 million in Q4 2021.
  • A 5-year average of $44.7 million and a median of $44.6 million in 2023 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): grew 11.87% in 2022, then grew 1.5% in 2023.
  • Biolife Solutions' Shares Outstanding (Diluted Average) stood at $38.5 million in 2021, then increased by 11.87% to $43.1 million in 2022, then rose by 1.5% to $43.7 million in 2023, then increased by 5.37% to $46.1 million in 2024, then rose by 5.6% to $48.6 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Shares Outstanding (Diluted Average) are $48.6 million (Q4 2025), $48.7 million (Q3 2025), and $47.5 million (Q2 2025).